Results 101 to 110 of about 8,085 (173)

HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies. [PDF]

open access: yesJ Neurol
Muñiz-Castrillo S   +8 more
europepmc   +1 more source

Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center Experience. [PDF]

open access: yesJ Clin Med
Melanis K   +14 more
europepmc   +1 more source

Significant improvement in paraneoplastic neurological syndromes without identifiable anti-neural antibodies in patients with breast cancer after breast surgery. [PDF]

open access: yesInt Cancer Conf J
Oshino T   +9 more
europepmc   +1 more source

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes. [PDF]

open access: yesAnn Clin Transl Neurol, 2017
van Coevorden-Hameete MH   +12 more
europepmc   +1 more source

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies. [PDF]

open access: yesJ Neurol Neurosurg Psychiatry, 2018
Berzero G   +14 more
europepmc   +1 more source

Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events. [PDF]

open access: yesIntern Med
Seki T   +10 more
europepmc   +1 more source

Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. [PDF]

open access: yesJAMA Neurol, 2015
Ariño H   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy